Maruyama S, Iwashita T, Imai T, Funahashi H, Ceccherini I, Luo Y, Romeo G, Matsuo S, Matsuyama M, Takahashi M
Department of Pathology, Nagoya University School of Medicine.
Jpn J Cancer Res. 1994 Sep;85(9):879-82. doi: 10.1111/j.1349-7006.1994.tb02962.x.
We investigated mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia (MEN) type 2A and type 2B. DNAs from pheochromocytomas and/or medullary thyroid carcinomas (MTCs) of five MEN 2A and three MEN 2B patients were amplified by a polymerase chain reaction (PCR) and analyzed. Tumors of four MEN 2A patients had missense mutations in Cys 634 in the extracellular domain of the ret proto-oncogene. The same mutations were detected in normal tissues of the patients, indicating that the mutations had arisen in the germ line. Using a reverse transcriptase(RT)-PCR, both normal and mutant transcripts of the ret proto-oncogene were detected in a tumor of one patient with MEN 2A mutation. In addition, three MEN 2B patients examined had the same point mutation (ATG-->ACG) at codon 918 in the tyrosine kinase domain of the ret proto-oncogene. Since all mutations identified in this study generated new restriction enzyme sites or eliminated a restriction site, the mutant alleles of affected family members could be readily detected without sequencing.
我们研究了日本2A型和2B型多发性内分泌腺瘤病(MEN)患者中ret原癌基因的突变情况。通过聚合酶链反应(PCR)扩增并分析了5例MEN 2A患者和3例MEN 2B患者的嗜铬细胞瘤和/或甲状腺髓样癌(MTC)的DNA。4例MEN 2A患者的肿瘤在ret原癌基因胞外域的Cys 634处发生错义突变。在这些患者的正常组织中也检测到相同的突变,表明这些突变发生在生殖系。使用逆转录酶(RT)-PCR,在1例携带MEN 2A突变的患者肿瘤中检测到ret原癌基因的正常和突变转录本。此外,检测的3例MEN 2B患者在ret原癌基因酪氨酸激酶域的第918密码子处有相同的点突变(ATG→ACG)。由于本研究中鉴定的所有突变都产生了新的限制性酶切位点或消除了一个限制性酶切位点,因此无需测序即可轻松检测受影响家庭成员的突变等位基因。